Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Feb;48(2):172-7.
doi: 10.1097/MCG.0b013e3182a030c4.

The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis

Raxitkumar Jinjuvadia  1 , Suhag Patel, Suthat Liangpunsakul
Affiliations
Meta-Analysis

The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis

Raxitkumar Jinjuvadia et al. J Clin Gastroenterol. 2014 Feb.

Abstract

Background: The metabolic syndrome (MetS) and/or its individual components have been linked to the development of cancer. Recent studies have suggested a similar link to hepatocellular carcinoma (HCC). The aim of this study was to evaluate the direction and magnitude of the association between the MetS and HCC.

Methods: Two reviewers independently conducted a systemic search to identify the available evidence from databases from January 1980 to June 2012. Search terms included "Metabolic syndrome," "insulin resistance syndrome," "metabolic abnormalities" combined with "hepatocellular carcinoma," and "liver cancer." No language restriction was applied to the search. Only studies reporting an effect measure for the association between MetS and HCC were eligible for inclusion. Publication bias was assessed using the Begg and Egger tests, with a visual inspection of funnel plot. All analyses were performed using Comprehensive Meta-analysis version 2 software.

Results: Four studies (3 cohort and 1 case control) with a total of 829,651 participants were included in the analysis. The age range of participants was between 30 and 84 years. The combined analysis showed an overall 81% increased risk of HCC in cases with MetS (relative risk, 1.81; 95% confidence interval, 1.37-2.41). After excluding the single case-control study from analysis, the overall risk ratio remained statistically significant (relative risk, 1.49; 95% confidence interval, 1.27-1.74). Funnel plot inspection, Begg and Egger tests showed no evidence of publication bias for combined analysis.

Conclusions: Though studies are scarce, currently available epidemiologic data are suggestive of significantly higher risk of HCC among patients with MetS.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: none

Figures

Figure 1
Figure 1
Study selection
Figure 2
Figure 2
Forest plot: Association between metabolic syndrome and Hepatocellular carcinoma
Figure 3
Figure 3
Funnel plots for publication bias: A) all studies, B) only cohort studies
See this image and copyright information in PMC

Comment in

References

    1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118–27. Epub 2011/10/14. - PubMed
    1. Siegel AB, Zhu AX. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer. 2009;115(24):5651–61. Epub 2009/10/17. - PMC - PubMed
    1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421. Epub 2002/12/18. - PubMed
    1. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709–16. Epub 2002/12/04. - PubMed
    1. Cowey S, Hardy RW. The metabolic syndrome: A high-risk state for cancer? Am J Pathol. 2006;169(5):1505–22. Epub 2006/10/31. - PMC - PubMed

Publication types